Physiologically Based Pharmacokinetic Modeling Approaches for Patients With SARS‐CoV‐2 Infection: A Case Study With Imatinib

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, which causes coronavirus disease 2019 (COVID‐19), manifests as mild respiratory symptoms to severe respiratory failure and is associated with inflammation and other physiological changes. Of note, substantial increases in plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Adiwidjaja, Jeffry, Adattini, Josephine A., Boddy, Alan V., McLachlan, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Physiologically Based Pharmacokinetic Modeling
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088354/
https://www.ncbi.nlm.nih.gov/pubmed/35460539
http://dx.doi.org/10.1002/jcph.2065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088354/
https://www.ncbi.nlm.nih.gov/pubmed/35460539
http://dx.doi.org/10.1002/jcph.2065

Ejemplares similares